Death by confounding: Bias and mortality

International Journal of Clinical Practice

Volumn 64, Issue 8, 2010, Pages 1009-1014

  Ghaemi, S N ^a   Thommi, S B ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; FLUOXETINE; HALOPERIDOL; NORTRIPTYLINE; OLANZAPINE; PERPHENAZINE; PLACEBO; QUETIAPINE; RISPERIDONE; THIORIDAZINE;

CARDIOVASCULAR RISK; CONFOUNDING VARIABLE; DATA BASE; DEATH; DEPRESSION; FOLLOW UP; HUMAN; MORTALITY; OBSERVATION; OBSERVER BIAS; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; STROKE; SUICIDE ATTEMPT; SYSTEMATIC ERROR; TREATMENT DURATION;

CONFOUNDING FACTORS (EPIDEMIOLOGY);

EID: 77953817164     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2010.02438.x     Document Type: Review

References (23)

1. Ghaemi SN. A Clinician's Guide to Statistics and Epidemiology in Mental Health: Measuring Truth and Uncertainty.
2. Tavani A, Vecchia CL. Coffee and cancer: a review of epidemiological studies, 1990-1999. Eur J Cancer Prev 2000 9 : 241.
3. Carmody TP, Brischetto CS, Matarazzo JD, O'Donnell RP, Connor WE. Co-occurrent use of cigarettes, alcohol, and coffee in healthy, community-living men and women. Health Psychol 1985 4 : 323 335.
4. Rothman KJ. Epidemiology: An Introduction.
5. Ghaemi SN, Exist D, Animals PWH, Into I, Adults D. Why evidence-based medicine can, and must, be applied to psychiatry. Psychiatric Times 2008 25 : 1 2.
6. Jorge RE, Robinson RG, Arndt S, Starkstein S. Mortality and poststroke depression: a placebo-controlled trial of antidepressants. Am J Psychiatry 2003 160 : 1823 1829.
7. Sonis J. Mortality and poststroke depression. Am J Psychiatry 2004 161 : 1506 1507 author reply 1507-8.
8. Rothman K, Greenland S. Modern Epidemiology.
9. Lang JM, Rothman KJ, Cann CI. That confounded P-value. Epidemiology 1998 9 : 7 8.
10. Tiihonen J, Lonnqvist J, Wahlbeck K, Klaukka T, Tanskanen A, Haukka J. Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort. Arch Gen Psychiatry 2006 63 : 1358 1367.
11. Reid S. Clozapine: first-line treatment for schizophrenia? In : Blogs BG, eds. HeadtoHead.
12. Miettinen OS, Cook EF. Confounding: essence and detection. Am J Epidemiol 1981 114 : 593 603.
13. Thomas AJ, Eberly LE, Davey Smith G, Neaton JD. ZIP-code-based versus tract-based income measures as long-term risk-adjusted mortality predictors. Am J Epidemiol 2006 164 : 586.
14. Single E, Robson L, Rehm J, Xie X, Xi X. Morbidity and mortality attributable to alcohol, tobacco, and illicit drug use in Canada. Am J Public Health 1999 89 : 385.
15. Shirzadi AA, Ghaemi SN. Side effects of atypical antipsychotics: extrapyramidal symptoms and the metabolic syndrome. Harv Rev Psychiatry 2006 14 : 152 164.
16. Association AD. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 2004 27 : 596 601.
17. Henderson DC, Nguyen DD, Copeland PM et al. Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study. J Clin Psychiatry 2005 66 : 1116 1121.
18. Levin A. Schizophrenia's suicide risk may be less than thought. Psychiatr News 2005 40 : 48.
19. Osborn DPJ, Levy G, Nazareth I, Petersen I, Islam A, King MB. Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Research Database. Arch Gen Psychiatry 2007 64 : 242.
20. Kelly DL, McMahon RP, Liu F et al. Cardiovascular disease mortality in patients with chronic schizophrenia treated with clozapine: a retrospective cohort study. J Clin Psychiatry 2010 71 : 304 311.
21. Alvir JMJ, Lieberman JA, Safferman AZ, Schwimmer JL, Schaaf JA. Clozapine-induced agranulocytosis. N Engl J Med 1993 329 : 162 167.
22. Salsburg D. The Lady Tasting tea: How Statistics Revolutionized Science in the Twentieth Century.
23. Feynman RP. Surely You're Joking Mr. Feynman. W. W. Norton & Company, NY.